Acute effects of 17β-estradiol on the coronary microcirculation: Observations in sedated, closed-chest domestic swine

Coronary Artery Disease

Volumn 8, Issue 6, 1997, Pages 351-361

  Berman, Mark ^a   Gewirtz, Henry ^b,c  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

17 estradiol; Coronary microcirculation; Diastolic resistance; Sexual dimorphism

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASTRATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DIASTOLE; FEMALE; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; MALE; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SEDATION; SEX DIFFERENCE; SWINE; VASODILATATION;

EID: 0030768581     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199706000-00004     Document Type: Article

References (42)

1. Stampfer MJ, Willett WC, Colditz GA: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985, 313:104-109.
2. Meade TW, Berra A: Hormone replacement therapy and cardiovascular disease. Br Med Bull 1992, 48:276-308.
3. Kalin MF, Zumoff B: Sex hormones and coronary disease. A review of clinical studies. Steroids 1990, 55:330-352.
4. Knoop RH: Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am J Obstet Gynecol 1988, 158:1630-1643.
5. Wenger NK, Packard B: Cardiovascular health and disease in women. W Engl J Med 1993, 329:247-256.
6. Williams JK, Adams MR, Herrington DM, Clarkson TB: Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992, 20:452-457.
7. Williams JK, Adams MR, Klopfenslein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990, 81:1680-1687.
8. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, et al.: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994, 89:52-60.
9. Collms P, Rosano GM, Sarrel RM, Ulrich L, Adamopoulos S, Beale CM, et al.: 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease [see comments]. Circulation 1995, 92:24-30.
10. Gilligan DM, Quyyumi AA, Cannon ROI: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994, 89:2545-2551.
11. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, et al.: Mechanism of estrogen induced vasodilatation: In vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol 1995, 26:807-814.
12. Hale SL, Alker KJ, Kloner RA: Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988, 78:428-434.
13. Nuwayhid B, Brinkman CR, Woods JRJ. Martinek H, Assali NS: Effects of estrogens on systemic and regional circulations in normal and renal hypertensive sheep. Am J Obstet Gynecol 1975, 123:495-504.
14. Rosenfeld CR, Mornss FHJ, Battaglia FC, Makowski EL, Meschia G: Effect of estradiol-17β on blood flow to reproductive and nonproductive tissues in pregnant ewes. Am J Obstet Gynecol 1976, 124:618-629.
15. Rosenfeld CR, Rivera R: Circulatory responses to systemic infusions of estrone and estradiol-17β in nonpregnant, oophorectomized ewes. Am J Obstet Gynecol 1978, 132:442-448.
16. Magness RR, Rosenfeld CR: Local and systemic estradiol-17: Effects on uterine and systemic vasodilation. Am J Physiol 1989, 256:E536-E542.
17. Witt BR, Thorneycroft IH: Reproductive steroid hormones: Generation, degradation, reception, and action. Clin Obstet Gynecol 1990. 33:563-575.
18. Taggart H, Stout RW: Control of DMA synthesis in cultured vascular endothelial and smooth muscle cells - response to serum, platelet deficient serum, lipid free serum, insulin and oestrogen. Atherosclerosis 1980, 37:549-557.
19. Gewirtz H, Brautigan DL, Olsson RA, Brown P, Most AS: Role of adenosine in the maintenance of coronary vasodilation distal to a severe coronary stenosis: Observations in conscious domestic swine. Circ Res 1983, 53:42-51.
20. Mills I, Fallon JT, Wrenn D, Sasken HF, Gray W, Bier J, et al.: Adaptive responses of the coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol 1994. 266:H447-H457.
21. Gray W, Bier J, Gewirtz H: Does EDRF play an important role in regulation of basal arteriolar tone in the normal coronary circulation [abstract]. Circulation 1990, 82 (suppl III):III407.
22. Chu A, Chambers DE, Lin CC, Kuehl WD, Cobb FR: Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol 1990, 258:H1250-H1254.
23. Broten TP, Miyashiro JK, Moncada S, Feigl EO: Role of endothelium derived relaxing factor in parasympathetic coronary vasodilation. Am J Physiol 1992, 262:H1579-H1584.
24. Jones CJH, Kuo L, Davis MJ, DeFily DV, Chilian WM: Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 1995, 91:1807-1813.
25. Colburn P, Buonassisi V: Estrogen binding sites in endothelial cell culture. Science 1978, 201:817-819.
26. Gisclard V, Miller VM, Vanhoutte PM: Effect of 17β-estradiol on endothelium dependent responses in the rabbit J Pharmacol Exp Ther 1988, 244:19-22.
27. Brady AJB, Poole-Wilson PA, Williams TJ, Harding SE: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1992, 265:H176-H186.
28. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P: Endothelium independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991, 104:1033-1037.
29. Collins P, Shay J, Jiang C, Moss J: Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994, 90:1964-1968.
30. Van Buren GA, Yang D, Clark KE: Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstel Gynecol 1992, 167:828-833.
31. Sugioka JM, Shimosegawa Y, Nakano NM: Estrogens a natural antioxidants of membrane lipid peroxidation. FEBS Lett 1987, 210:37-39.
32. Gerhard M, Ganz P: How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 1995, 92:5-8.
33. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz L: A new nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 1992, 131:1304-1312.
34. Harder DR, Coulson PB: Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol 1979, 100:375-382.
35. Cowan CL, Palacino JJ, Najibi S, Cohen RA: Potassium channel-mediated relaxation to acetylcholine in rabbit arteries. J Pharmacol Exp Ther 1993, 266:1482-1489.
36. Collins P, Sheppard M, Beale CM, Dowsett M: The classical estrogen receptor is not found in human coronary arteries [abstract]. J Am Coll Cardiol 1996, 27:272A.
37. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM: Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994, 89:1501-1510.
38. Iafrati MD, Karas RH, Aronovitz M, Sung K, Sullivan TR, Lubahn DB, et al.: Estrogen inhibits the vascular injury response of estrogen receptor α-deficient mice. Nature Med 1997, 3:545-548.
39. While RE, Darkow DJ, Lang JLF: Estrogen relaxes coronary arteries by opening BK(Ca) channels through a cGMP-dependent mechanism. Circ Res 1995, 77:936-942.
40. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM: Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 1993, 264:H1734-H1739.
41. Tschudi M, Richard V, Buhler FR, Luscher TF: Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 1991, 260:H13-H20.
42. Vainer SF, Hintze TH: Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Circulation 1982, 66:579-588.